Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized dexamethasone use in triple antiemetic therapy during concurrent chemoradiotherapy for cervical cancer
ChiCTR2500105475Phase 3Recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexamethasone in Cervical Cancer (CC) (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoints: Adverse events, Complete prevention rate and 1 more. Started Jul 2025; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2500105475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105475.